Here are some of the top investing stories you may have missed. Two Cannabis Stocks that Could Move to a Major Exchange in 2019 An estimated 64 million Americans have tried some form of CBD in the last 24 months, with nearly one out of seven using the compound every day, according to a Consumer…
DetailsOriginal Post. Gold was headed for its first losing session in nine on Monday, tumbling as encouraging global trade headlines drove investors away from the metal and into perceived riskier assets such as stocks, while the dollar gained. To read more on this developing story, click here.
DetailsOriginal Post. Markets are pretty confident that central banks are about to enter a period of easing up on interest rates. When the US jobs report came in well below expectations on Friday, stocks moved higher. The reason? It could clear the way for the Federal Reserve to start cutting interest rates. Mark Cabana, rates strategist at Bank of…
DetailsThe cannabis story has taken on a life of its own. In 2018, Canada legalized its recreational use. Corporate America began investing in major cannabis companies. More U.S. states approved its recreational or medicinal use. The U.S. FDA approved its very first cannabis-derived drug. On top of that, an estimated 64 million Americans have tried…
DetailsShortly after new U.S. tariffs were announced in May 2019, the S&P 500 lost $1.2 trillion. Shortly after that, China retaliated, announcing tariffs on $60 billion worth of U.S. goods, making the situation so much more “fun” that it already was. Worse, according to analysts at the time, “Our view is this could escalate for…
DetailsMarkets pulled back sharply earlier this week. And it wasn’t just because of the trade war. This time, falling knives in big tech forced the NASDAQ into correction territory. All thanks to antitrust regulator’s plans that could lead to broader oversight on Facebook, Google, and Amazon. Amazon.com (AMZN) Shares of Amazon were down $81.50, or…
DetailsOriginal Post. The next 5 days will be extremely busy: Trump in the UK, Xi in Russia, the US jobs report on Friday, the ECB on Thursday. Of course, with markets buffeted by renewed fears over a global trade war and growing fears of a recession, it’s hard to see that as being anything but…
DetailsOriginal Post. Quest Diagnostics, one of the biggest blood testing providers in the country, warned Monday that nearly 12 million of its customers may have had personal, financial and medical information breached due to an issue with one of its vendors. To read more on this developing story, click here.
DetailsAll eyes are on the U.S. FDA with key hearings seeking information on cannabis with an aim of creating a regulatory framework for CBD. “The public hearing will give stakeholders an opportunity to provide the FDA with additional input relevant to the agency’s regulatory strategy related to existing products, as well as the lawful pathways…
DetailsAfter weeks of intense fighting between the two economic superpowers, major indices plummeted in late May 2019. All after the press reported the U.S. was considering restrictions on Hikvision – a Chinese surveillance equipment provider – from buying U.S. components. “The U.S. is considering cutting off the flow of vital American technology to as many…
DetailsThings have gotten way out of hand with the trade war. After weeks of intense fighting between the two economic superpowers, Dow futures are pointing to a 230-point drop at the open today. All after the press reported the U.S. was considering restrictions on Hikvision – a Chinese surveillance equipment provider – from buying U.S.…
DetailsHere are some of the top investing stories you may have missed. Trade War 2019: How to Protect Your Portfolio as the War Intensifies At the start of May 2019, we warned volatility could be a problem. All as trade war fears continue to mount. In fact, as this is being written, Dow futures were…
Details